CN Patent

CN106316967B — 西里帕格中间体及西里帕格的制备方法

Assigned to SHANGHAI ACANA PHARMTECH Co Ltd · Expires 2019-02-05 · 7y expired

What this patent protects

本发明属于化学制备领域,涉及一种西里帕格中间体及西里帕格的制备方法;所述西里帕格中间体为化合物SLP‑4 化合物SLP‑7 化合物SLP‑8 化合物SLP‑10 本发明提供的西里帕格的制备方法具有路线合理、原料易得、成本低廉、操作难度低、对环境污染小等优点,使得本发明的方法能够满足大规模工业化生产的要求。

USPTO Abstract

本发明属于化学制备领域,涉及一种西里帕格中间体及西里帕格的制备方法;所述西里帕格中间体为化合物SLP‑4 化合物SLP‑7 化合物SLP‑8 化合物SLP‑10 本发明提供的西里帕格的制备方法具有路线合理、原料易得、成本低廉、操作难度低、对环境污染小等优点,使得本发明的方法能够满足大规模工业化生产的要求。

Drugs covered by this patent

Patent Metadata

Patent number
CN106316967B
Jurisdiction
CN
Classification
Expires
2019-02-05
Drug substance claim
No
Drug product claim
No
Assignee
SHANGHAI ACANA PHARMTECH Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.